Bioabsorbable metals hold a lot of potential as orthopaedic implant
materials. Three metal families are currently being investigated: iron
(Fe), magnesium (Mg) and zinc (Zn). Currently, however, biodegradation
of such implants is poorly predictable. We thus used Direct Metal
...
Bioabsorbable metals hold a lot of potential as orthopaedic implant
materials. Three metal families are currently being investigated: iron
(Fe), magnesium (Mg) and zinc (Zn). Currently, however, biodegradation
of such implants is poorly predictable. We thus used Direct Metal
Printing to additively manufacture porous implants of a standardized
bone-mimetic design and evaluated their mechanical properties and
degradation behaviour, respectively, under in vivo-like conditions.
Atomized powder was manufactured to porous implants of repetitive
diamond unit cells, using a ProX DMP 320 (Layerwise, Belgium) or a
custom-modified ReaLizer SLM50 metal printer. Degradation behaviour was
characterized under static and dynamic conditions in a custom-built
bioreactor system (37ºC, 5% CO2 and 20% O2) for up of 28 days. Implants were characterized by micro-CT before and after in vivo-like
degradation. Mechanical characterization (according to ISO 13314: 2011)
was performed on an Instron machine (10kN load cell) at different
immersion times in simulated body fluid (r-SBF). Morphology and
composition of degradation products were analysed (SEM, JSM-IT100,
JEOL). Topographically identical titanium (Ti-6Al-4V, Ti64) specimen
served as reference.
Micro-CT analyses confirmed average strut sizes (420 ± 4 μm), and
porosity (64%), to be close to design values. After 28 days of in vivo-like
degradation, scaffolds were macroscopically covered by degradation
products in an alloy-specific manner. Weight loss after cleaning also
varied alloy-specifically, as did the change in pH value of the r-SBF.
Corrosion time-dependent changes in Young's moduli from 1200 to 800 MPa
for Mg, 1000 to 700 MPa for Zn and 48-8 MPa for iron were statistically
significant.
In summary, DMP allows to accurately control interconnectivity
and topology of implants from all three families and micro-structured
design holds potential to optimize their degradation speed. This first
systematic report sheds light into how design influences degradation
behaviour under in vivo-like conditions to help developing new standards for future medical device evaluation.@en